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Mitochondrial dysfunction is implicated in neurodegenerative disorders, such as
Alzheimer’s disease (AD). Translocase of outer mitochondrial membrane 40 (TOMM40)
may be influential in this regard by influencing mitochondrial neurotoxicity. Little is known
about the influence of the TOMM40 gene on hippocampal (HC) volume and episodic
memory (EM), particularly in healthy older adults. Thus, we sought to discern the
influence of TOMM40 single nucleotide polymorphisms (SNPs), which have previously
been associated with medial temporal lobe integrity (rs11556505 and rs2075650), on HC
volume and EM. The study sample consisted of individuals from the Swedish National
Study on Aging and Care in Kungsholmen (SNAC-K) who were free of dementia and
known neurological disorders, and 60–87 years of age (n = 424). EM was measured
by using a 16-item word list with a 2-min free recall period and delineation of the HC
was performed manually. The influence of Apolipoprotein E (APOE) and TOMM40 was
assessed by 2× 2 ANOVAs and partial correlations. There was no effect of APOE and
TOMM40 on EM performance and HC volume. However, partial correlations revealed that
HC volume was positively associated with free recall performance (r = 0.21, p < 0.01,
r2 = 0.04). When further stratified for TOMM40, the observed association between HC
volume and free recall in APOE ε4 carriers was present in combination with TOMM40
rs11556505 any T (r = 0.28, p < 0.01, R2 = 0.08) and rs2075650 any G (r = 0.28, p < 0.01,
R2 = 0.08) “risk” alleles. This pattern might reflect higher reliance on HC volume for
adequate EM performance among APOE ε4 carriers with additional TOMM40 “risk”
alleles suggesting that the TOMM40 gene cannot merely be considered a marker of APOE
genotype. Nevertheless, neither APOE nor TOMM40 influenced HC volume or EM in this
population-based sample of cognitively intact individuals over the age of 60.
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INTRODUCTION
Although much is known about the clinical manifestations of
Alzheimer’s disease (AD), the etiology and pathophysiology of
this disease still remains to be determined. Mitochondrial dys-
function is becoming increasingly highlighted in both pathologi-
cal and non-pathological aging (Lin and Beal, 2006; Reddy et al.,
2010; Swerdlow, 2011; Ferencz et al., 2012). Previously only con-
sidered in unison with APOE, due to linkage disequilibrium (LD)
between the two genes, TOMM40 was recently found to inde-
pendently influence age of onset of AD (Roses et al., 2010; Li
et al., 2012). In addition TOMM40 has been associated with risk
of AD (Grupe et al., 2007; Abraham et al., 2008; Harold et al.,
2009). However, these findings have not been consistently repli-
cated (Cruchaga et al., 2011; Guerreiro andHardy, 2012; Jun et al.,
2012) and it is unclear if the effect can be attributed to TOMM40
or APOE as the two genes are in strong LD. Moreover, there is
limited information on the influence of other TOMM40 SNPs,
besides the rs10524523 poly-T length, on age- and AD-sensitive
markers, such as hippocampal (HC) volume and episodic mem-
ory (EM). Thus, further research is required in normal old adults
before we can tease out the influence of genetic variation in APOE
and TOMM40 on HC volume and EM memory, irrespective of
dementia.
TOMM40, codes for the outer mitochondrial membrane pore
subunit (TOM40), which is a pore through which proteins read-
ily enter the mitochondria (Humphries et al., 2005). Known as
the “powerhouse” of all cells, mitochondria serve an important
function in the central nervous system, providing energy essen-
tial for neuronal survival (McBride et al., 2006; Baloyannis, 2011).
Not always beneficial to the neurons, an increased net production
of reactive oxygen species in mitochondria has been implicated
in both pathological and non-pathological aging (Lin and Beal,
2006). Moreover, morphological changes within the mitochon-
dria of the hippocampus have been observed in postmortem AD
(Hirai et al., 2001; Baloyannis, 2011). The mitochondrial import
channel (TOM40) has been implicated in AD as an important site
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of amyloid precursor protein (APP) accumulation, which in turn
is thought to trigger downstream events leading to an increase
in reactive oxygen species (H2O2) and mitochondrial dysfunc-
tion. Interestingly, APP accumulation within the mitochondrial
import channels was found across cholinergic, dopaminergic,
glutamatergic, and GABAergic neuron types in AD and was
more abundant in frontal cortex and the HC (Devi et al., 2006).
However, we do not know whether TOMM40 SNPs influence the
channel forming subunit that is implicated as a site where APP
accumulates. Nonetheless, it is possible that genetic variation in
or close to TOMM40 changes the function of the TOM40 pro-
tein, thereby influencing mitochondrial functioning in areas such
as the HC (Ferencz et al., 2012), but this proposed mitochondrial
disconnection hypothesis has yet to be confirmed.
Recently, TOMM40 rs2075650 was associated with AD, and
deemed the second most significant AD marker in the APOE
region (Harold et al., 2009; Feulner et al., 2010). The strong
Genome Wide Association Study (GWAS) signal for TOMM40
rs2075650 is interpreted as an APOE hit, due to their strong LD,
and often the biological implications are considered to originate
from APOE. Interestingly, the rs2075650, rs11556505 (TOMM40)
and rs429358 (APOE) haplotype show greater genome wide asso-
ciation with AD than TOMM40 rs20756505 alone (Potkin et al.,
2009). HC atrophy is common, albeit not always present, in the
preclinical course of AD (Reitz et al., 2011; Tondelli et al., 2011;
Lindberg et al., 2012) and the APOE ε4 allele has been shown
to influence HC atrophy in prodromal AD (Jack et al., 2012).
TOMM40 may have an additional influence on this trajectory, as
TOMM40 rs2075650 has been associated with HC integrity (Shen
et al., 2010; Bis et al., 2012; Vounou et al., 2012). A recent GWAS
on imaging phenotypes by Shen and colleagues (2010) found that
both APOE and TOMM40 were associated with multiple imaging
phenotypes. Interestingly, TOMM40 rs2075650 was specifically
associated with HC and right amygdala volume, in comparison
to the APOE ε4 allele that was linked to volumes throughout the
brain including neocortical areas (parietal and temporal cortices)
and the hippocampus. Thus, TOMM40 may have a more specific
role within the medial-temporal lobe compared to APOE, which
may apply primarily to TOMM40 rs2075650 G, and possibly to
rs11556505 T.
It is well-established that HC integrity is pivotal to EM per-
formance (Milner, 1972; Tulving and Markowitsch, 1998; Squire
et al., 2004). Whereas the ε4 allele of the APOE gene has been
linked to impaired EM performance (Small et al., 2004; Nilsson
et al., 2006; De Jager et al., 2012), the influence of TOMM40 SNPs
on memory has rarely been investigated. Yet, the TOMM40 poly-
T length has been found to negatively influence EM (Johnson
et al., 2011), but this influence may not be independent of APOE
(Schiepers et al., 2012), nor always replicable (Cruchaga et al.,
2011). Recently, the TOMM40 poly-T length was found to inde-
pendently modulate the adverse effects of lorazepam-induced
memory impairment in aging (Pomara et al., 2011a). It remains
to be determined whether TOMM40 rs11556505 and rs2075650
SNPs influence EM in normal aging.
In the past years, the impact of genes on brain and cogni-
tion has been highlighted (Rasch et al., 2010; Wilson et al., 2011),
with increasing focus on the synergistic effects of different single
nucleotide polymorphisms (SNPs) (Eichler et al., 2010). Thus, the
primary aim of this study was to assess the influence of variations
in the TOMM40 gene on HC volume and EM in old adults (>60)
without dementia, taking into account APOE genotype status.
We analyzed two TOMM40 SNPs (rs11556505 and rs2075650),
which have previously been associated with onset of AD (Grupe
et al., 2007; Harold et al., 2009; Potkin et al., 2009; Feulner et al.,
2010) and HC integrity (Shen et al., 2010; Bis et al., 2012; Vounou
et al., 2012). We hypothesized that these TOMM40 SNPs have an
influence on HC volume and EM performance, irrespective of
APOE status, with rs2075650 G and rs11556505 T “risk alleles”
negatively influencing the dependent variables.
MATERIALS AND METHODS
ETHICS STATEMENT
For the current analyses a subsample of participants from the
baseline assessment of the Swedish National Study on Aging and
Care in Kungsholmen (SNAC-K) was used. The SNAC-K study
complies with the declaration of Helsinki, and has been approved
by the ethical committee at Karolinska Institutet. All subjects gave
informed consent, and in the case of severe cognitive impairment
consent was collected from next-of-kin.
STUDY SAMPLE
The SNAC-K study commenced in 2001, inviting randomly
selected participants from the island of Kungsholmen in central
Stockholm to examine medical, psychological, and social aspects
of health in late adulthood (Laukka et al., 2013). Three thou-
sand three hundred and sixty three individuals participated in
baseline assessments that consisted of neuropsychological testing,
medical screening and nurse interviews. The participants were
randomly selected from eleven age cohorts: 60, 66, 72, 78, 81, 84,
87, 90, 93, 96, and 99 years and older. For the current analyses,
we used a sample of 555 randomly selected non-institutionalized
individuals from SNAC-K, who underwent magnetic resonance
imaging (MRI). DNA and neuropsychological assessments were
available for 496 of these individuals. After exclusions based on
the following criteria: age 90 and above (n = 14), major depres-
sive episode according to DSM-IV (n = 1), MMSE ≤ 24 (n =
2), Guillain–Barré syndrome (n = 1), epilepsy (n = 2), alcohol
dependence syndrome (n = 3), dyslexia (n = 3), stroke (n = 19),
and suboptimal MRI image quality (n = 27), the final study sam-
ple comprised 424 individuals between 60 and 87 years of age.
The mean age of the participants was 69.91 years (SD = 8.63);
they had received on average 12.61 years of schooling, had a mean
Mini-Mental State Examination score of 29.17 (SD = 1.00), and
the majority of the sample was female (59.30%).
MRI ACQUISITION AND VOLUMETRIC MEASUREMENT
MRI data were acquired on a 1.5 T scanner (Philips Intera,
Netherlands). 3D fast field echo (FFE) T1, axial SE (spin
echo) Proton Density/T2, axial FLAIR (fluid-attenuated inver-
sion recovery), and axial diffusion tensor imaging data were
acquired. The 3D FFE T1 images (TR = 15ms, TE = 7ms, Flip
angle = 15◦, number of axial slices = 128 with thickness =
1.5mm and in plane resolution 0.9375 × 0.9375, no gap, Field
Of View = 240 × 240, matrix = 196 × 256) were used for
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volumetry. Volumetric measurements of the HC were performed
manually on the HERMES workstation (Nuclear Diagnostics,
Stockholm, Sweden) by a radiologist who was blind to the par-
ticipants’ genotype status. The HC formation was defined as
gray matter including the HC proper (Ammon’s horn), the den-
tate gyrus, the subiculum and some white matter (alveus, fim-
bria). The parahippocampal gyrus, entorhinal cortex, and fornix
were excluded (Zhang et al., 2010). Intracranial volume (ICV)
was acquired using STEREOLOGY (Sheline et al., 1996) in the
HERMES workstation and included total brain, dura, ventri-
cles, extraventricular CSF, brain stem, and cerebellum. Intra-rater
reliability of 15 randomly selected subjects provided intraclass
correlation coefficients above 0.93 for the HC and ICV. Left
HC volume (M = 3.33 cm3, SD = 0.50) and right HC volume
(M = 3.41 cm3, SD = 0.48) were highly correlated (r = 0.83,
p < 0.00). Thus, volumes from both hemispheres were com-
bined, yielding an overall HC volume of (M = 6.74 cm3, SD =
0.89). We corrected for head size in all analyses by adding ICV as a
covariate.
NEUROPSYCHOLOGICAL ASSESSMENT
EM was measured using a 16-item word list. Sixteen unrelated
concrete nouns were presented to participants both visually and
orally. Presentation rate was 5 s per word followed by a 2-min
free recall period. We used total number of words recalled as a
measure of free recall.
GENOTYPING
DNAwas extracted from peripheral blood samples using standard
methods. Genotyping was performed using MALDI-TOF anal-
ysis on the Sequenom MassARRAY™ platform at the Mutation
Analysis Facility, Karolinska Institutet. DNA was amplified using
primer pairs to identify SNP loci, followed by assessing the
allele-specific extension products by their respective mass, using
MassARRAY MALDI-TOF mass spectrometry. Quality control
was performed at the DNA-sample level, assay level, and the level
of multiplex assay pool. The call rates for the SNPs included in
this study were between 99.4 and 99.7%. Concordance analysis
was done on 486 DNA samples that were present twice, and 14
DNA samples that were present in triplets, and analyzed in sep-
arate runs. Analysis performed on all assays passing the quality
controls, yielded a concordance score>99%.
We targeted two TOMM40 polymorphisms: rs11556505 and
rs2075650 and for APOE we assessed the rs429358 SNP that
determines ε4 status. Dichotomized variables were created for
APOE rs429358 (no ε4 vs. any ε4) and TOMM40 rs11556505
(CC vs. any T) and rs2075650 (AA vs. any G). Allelic frequencies
(Table 1) were in line with previous reports and Hardy Weinberg
Equilibrium was p = 0.83 for rs429358, p = 0.01 for rs11556505
and p = 0.01 for rs2075650, all considered within the range of
established conventions. LD was calculated between TOMM40
and APOE SNPs using the statistical package SNPassoc in R
(Gonzalez et al., 2007). In the current sample TOMM40 SNPs
were in LD (D′max = 1), with APOE. Furthermore, the two
TOMM40 SNPs (rs11556505 and 2075650) were in high LD
(D′ = 1). However, their frequency was not completely over-
lapping and, therefore, they were considered separately in the
analyses.
STATISTICAL ANALYSES
We used IBM SPSS 19 for all analyses. Primary analyses to eval-
uate the genetic influence on EM included a series of analysis
of variance (ANOVAs), with dichotomized genotype groups as
factors i.e., APOE rs429358 (no ε4 vs. any ε4) and TOMM40
rs11556505 (CC vs. any T) and EM free recall as dependent vari-
able. This way both main and interaction effects of APOE and
TOMM40 were facilitated. To assess the influence of the APOE
and TOMM40 SNPs on HC volume a series of analysis of covari-
ance (ANCOVA) were conducted, with ICV as a covariate. Second
order partial correlations, controlling for age and ICV, were con-
ducted in order to assess the association between EM and HC
volume. To ascertain if there was a statistical difference between
correlation coefficients Fisher’s z transformation (Fisher, 1915)
was utilized.
RESULTS
THE INFLUENCE OF APOE AND TOMM40 ON EM
2 × 2 ANOVAs were performed to assess the influence of APOE
and TOMM40 on EM free recall, one model per TOMM40
SNP. Demographic variables are displayed in Table 2 and dif-
ferences were analyzed using ANOVAs. There was no main
effect of the APOE polymorphism on free recall performance
(Figure 1A), meaning that presence or absence of the ε4 allele
had no influence on EM in the current sample [F(1, 409) = 0.49,
p = 0.486]. Furthermore, neither TOMM40 SNPs, rs20756505
[F(1, 409) = 0.29, p = 0.589] nor rs11556505 [F(1, 408) = 0.29,
p = 0.589], had a significant influence on free recall perfor-
mance (Figures 1B,C). Finally, we observed no interaction effects
between the APOE and TOMM40 SNPs on the dependent vari-
able free recall (1) rs20756505 [F(1, 409) = 0.25, p = 0.621], (2)
rs11556505 [F(1, 408) = 0.23, p = 0.632]. The same pattern was
observed that is no main or interaction effects of APOE and
TOMM40 SNPs, when age, sex and education were adjusted for
using ANCOVAs (ps > 0.10).
Table 1 | Polymorphic characteristics of the APOE and TOMM40 gene.
SNP Gene Chr Position Frequencies Protein LD rs429358
rs429358 APOE 19 45411941 any ε4 27.2% Apolipoprotein E
rs2075650 TOMM40 19 45395619 any G 27.9% Tom40 D′ = 0.83
rs11556505 TOMM40 19 45396144 any T 27.5% Tom40 D′ = 0.83
LD, Linkage Disequilibrium measured in D′; TOMM40, Translocase of outer mitochondrial membrane 40; APOE, Apolipoprotein E; Chr, Chromosome.
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Table 2 | Demographic variables across APOE and TOMM40 status.
APOE no ε4 APOE any ε4
TOMM40 M SD M SD M SD M SD F P value
rs2075650 AA n = 271 Any G n = 30 AA n = 29 Any G n = 84
Age 69.80 8.5 71.73 9.5 70.69 9.4 69.88 8.9 0.52 0.67
Education 12.57 4.5 11.28 3.5 12.50 4.2 13.27 4.7 1.53 0.21
MMSE 29.24 0.9 28.97 0.9 29.04 1.2 29.02 1.1 1.68 0.17
Sex M/F 108/163 13/17 11/18 33/51 0.21† 0.98
rs11556505 CC n = 272 Any T n = 30 CC n = 29 Any T n = 82
Age 69.87 8.5 71.73 9.5 70.69 8.0 69.83 9.0 0.49 0.69
Education 12.57 4.5 11.28 3.5 12.41 4.3 13.31 4.7 1.61 0.19
MMSE 29.24 0.9 28.97 0.9 29.00 1.2 29.03 1.1 1.69 0.17
Sex M/F 109/163 13/17 11/18 33/49 0.19† 0.98
† = χ2; MMSE, Mini Mental State Examination; TOMM40, Translocase of outer mitochondrial membrane 40; APOE, Apolipoprotein E.
FIGURE 1 | Influence of the APOE and TOMM40 genes on episodic memory. Figures depict mean and standard deviation for free recall performance
(Number of words) and hippocampal (HC) volume (cm3) in APOE (A,D), TOMM40 rs20756505 (B,E) and rs11556505 (C,F).
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THE INFLUENCE OF APOE AND TOMM40 ON HC VOLUME
In order to assess the influence of the APOE and TOMM40 SNPs
onHC volumewe conducted 2 × 2 ANCOVAs, one per TOMM40
SNP, with HC volume as dependent variable. We included ICV
as a covariate in the model to ensure that there were no con-
founding effects on HC volume as a result of variation in ICV.
Running these ANCOVAs with APOE (rs429358) and TOMM40
(rs2075650 and rs11556505) resulted in no significant main effect
of APOE [F(1, 409) = 0.58, p = 0.447], or TOMM40 rs20756505
[F(1, 409) = 0.07, p = 0.799], rs11556505 [F(1, 408) = 0.01 p =
0.918] and no interaction effects (1) rs20756505 [F(1, 409) =
0.54 p = 0.462], (2) rs11556505 [F(1, 408) = 0.30 p = 0.583]
(Figures 1D–F). This suggests that neither APOE nor TOMM40
polymorphisms have a significant influence on HC volume in
individuals with no known neurodegenerative disorders, age
60–87. Again, no main or interaction effects were observed when
controlling also for age, sex and education (ps > 0.10).
To test if TOMM40 genotypes influenced the association
between EM and HC volume we conducted a series of partial
correlations between free recall and HC volume. All analyses
were controlled for age, which is known to influence HC vol-
ume in the SNAC-K sample (Zhang et al., 2010), as well as EM
(Rönnlund et al., 2005), and ICV (Sanfilipo et al., 2004). The
correlations were conducted in two steps; first analyzing the influ-
ence of APOE (non-ε4 vs. any ε4), followed by the influence of
TOMM40 rs2075650 (AA vs. any G) and rs11556505 (CC vs. any
T) in APOE ε4 carriers only. We observed a significant correla-
tion between HC volume and free recall performance in APOE
ε4 carriers (r = 0.21, p = 0.026), such that those carrying the
ε4 allele appear to require larger HC volume in order to per-
form well on free recall (Tulving and Craik, 2000), accounting for
4% of the variance (Figure 2B). This association was not signifi-
cant in APOE non-ε4 carriers (r = 0.06, p = 0.284) (Figure 2A),
and when tested with the Fisher z-transformation there was a
FIGURE 2 | The association between hippocampal volume and
episodic memory. Second order partial correlations, between free
recall performance and hippocampal volume, controlling for age and
intracranial volume. Panels (A,B) depicts initial partial correlations for
APOE non-ε4 vs. ε4 carriers, followed by partial correlations in
APOE ε4 carriers only according to TOMM40 dichotomization:
(C) rs2075650 AA, (D) rs2075650 any G, (E) rs11556505 CC,
(F) rs11556505 any T.
Frontiers in Human Neuroscience www.frontiersin.org May 2013 | Volume 7 | Article 198 | 5
Ferencz et al. Genetic influence on episodic memory
non-significant trend for differences between the correlations for
any ε4 and non-ε4 carriers (p = 0.09). Taking this association
one step further, we assessed whether the positive correlation
between HCvolume and free recall was influenced by the presence
or absence of TOMM40 “risk” alleles in APOE ε4 carriers only
(Figures 2D,F). The positive correlation between EM andHC vol-
ume was present among TOMM40 “risk” allele carriers rs2075650
(any G: r = 0.28, p = 0.012) and TOMM40 rs11556505 (any T:
r = 0.28, p = 0.013) carriers with any APOE ε4 allele, explaining
8% of the variance, in comparison to “non-risk” allele carri-
ers rs2075650 (AA: r = 0.16, p = 0.420) and rs11556505 (CC:
r = 0.19, p = 0.338) with anAPOE ε4 allele. Moreover,TOMM40
SNPs had no additional influence on the non-significant associ-
ation among APOE non-ε4 carriers (ps > 0.10). These findings
were replicated when also controlling for a sex and education
[APOE ε4 carriers and TOMM40 rs2075650 (any G: r = 0.28,
p = 0.012) and TOMM40 rs11556505 (any T: r = 0.28, p =
0.012)]. In order to correct for multiple comparisons we utilized
Bonferroni correction whereby the conventional level of signif-
icance (p < 0.05) was divided by the number of SNPs utilized
(n = 3), yielding a more stringent α-level of p < 0.016. Whereas
the association between HC volume and free recall performance
among APOE ε4 carriers did not survive correction, the associa-
tion amongAPOE ε4 carriers with TOMM40 risk alleles remained
significant (Figures 2D,F).
Upon closer examination of the correlation coefficients using
Fisher z transformation (Fisher, 1915) we observed that the cor-
relations were not significantly different in TOMM40 “risk” vs.
“non-risk” allele carriers with the presence of an APOE ε4 allele.
Removal of one influential case (>2 SD HC volume and EM
memory) in APOE ε4 carriers with an additionalTOMM40 “non-
risk” allele (Figures 2C,E), resulted in a reduction of the magni-
tude of the correlation coefficient from r = 0.16 to r = 0.06 for
rs2075650 (AA) and from r = 0.19 to r = 0.11 for rs11556505
(CC). Note that data are presented following removal of outliers.
Nevertheless, even with this reduced sample, Fishers z test (Fisher,
1915) resulted in no significant difference in correlation coeffi-
cients across TOMM40 genotypes (ps > 0.10). No other outliers
were present in the sample.
Finally, we confirmed the specificity of the association between
HC volume and free recall, using a battery of tasks assessing
semantic memory, verbal fluency and perceptual speed (Laukka
et al., 2013). For none of these task domains, the relationship
attained significance (ps > 0.10). All findings were replicated
following exclusion of participants (n = 12) with a preliminary
dementia diagnosis at follow-up, which took place 3 years after
baseline in the old cohorts (age≥ 78 at baseline) and 6 years after
baseline (age 60–78 at baseline), to ensure that the results were
not biased by the presence of preclinical AD cases.
DISCUSSION
The aim of the current study was to assess whether there is a dif-
ferential influence of APOE and TOMM40 polymorphisms on
HC volume and EM in non-demented older adults. Our find-
ings suggest that the APOE and TOMM40 SNPs examined do not
influence HC volume and EM performance in adults above 60
years of age.
Initial analyses revealed that there was no influence of the
APOE ε4 allele on free recall performance, which is in line with
previous research showing limited influence of APOE ε4 on
cognition in individuals free of dementia (Small et al., 2000),
especially when accounting for preclinical dementia (Savitz et al.,
2006; Laukka et al., 2013). Thus, our results do not provide sup-
port for a significant effect of the APOE ε4 allele on HC volume
and EM. Nonetheless, the primary aim of the current study was
to gauge the influence of TOMM40 SNPs on free recall and HC
volume. Although TOMM40 rs2075650 has been associated with
HC volume in AD (Shen et al., 2010), we observed no asso-
ciation between either TOMM40 rs11556505 nor rs2075650 on
HC volume in this sample of old cognitively normal individu-
als. Likewise, we did not find an association between TOMM40
SNPs and EM performance. Thus, it appears that these TOMM40
SNPs have no influence on HC volume and EM performance in
non-demented older adults as measured in this study.
Currently, the majority of research concerning the influence of
TOMM40 on cognition has been focused on the TOMM40 poly-
T repeat (rs10524523). Recently, Hayden and colleagues (2012)
observed that TOMM40 length variation within the rs10524523
SNP influenced cognition in normal aging, even when account-
ing for APOE. In the current sample, neither TOMM40 poly-
morphisms (rs2075650, rs11556505) had a direct influence on
cognition. Yet it is possible that the differential effect of APOE
and TOMM40 is age-dependent and therefore not present in
the current sample. A recent longitudinal study by Caselli and
colleagues (2012) demonstrated that variation in the TOMM40
poly-T length influences memory performance independently of
APOE variation prior to the age of 60. Moreover, our under-
standing of the biological expression of TOMM40 SNPs remains
limited. Indeed, a recent study by Hedskog and colleagues (2012)
found that the TOMM40 rs10524523 repeat length polymor-
phism (poly-T), had no detectable influence on mitochondrial
morphology when measured in fibroblasts in healthy individu-
als before 64 years of age. However, there is a lack of knowledge
regarding the influence of other TOMM40 polymorphisms on
mitochondrial functioning and morphology in individuals above
this age. A recent study by Bekris and colleagues (2012) showed
that regions within TOMM40, including TOMM40 poly-T and
rs2075650, are involved in APOE and TOMM40 gene regulation
by influencing promoter activity in certain haplotype structures
depending on haplotype and cell type. These findings suggest
that gene expression within the TOMM40 region is complex
and haplotype- as well as cell-dependent. However, despite some
implications from the literature of a TOMM40 component to EM
andHC volume, we were not able to confirm this association with
the current TOMM40 SNPs in our population based sample of
non-demented older individuals.
Whereas, a direct influence of TOMM40 variation was not evi-
dent in the current study, we observed a significant association
between HC volume and free recall performance in APOE ε4 car-
riers who also carried TOMM40 “risk alleles.” The relationship
between HC volume and EM in APOE ε4 carriers with the two
TOMM40 “risk alleles” were the only correlation that survived
correction for multiple testing. Moreover, the association between
HC volume and free recall in APOE ε4 carriers with TOMM40
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“non-risk alleles” was markedly reduced upon the removal of an
outlier, strengthening our hypothesis that the strongest associa-
tion is found in APOE ε4 carriers with TOMM40 “risk alleles.”
Although the association was primarily present in APOE ε4 car-
riers who also carry TOMM40 “risk alleles” it should be noted
that the correlation coefficients in question were not significantly
different and the lack of association in APOE ε4 carriers with
TOMM40 “non-risk alleles” may reflect small sample size in this
group.
Nevertheless, the positive association between HC volume and
free recall performance indicates that APOE ε4 allele carriers who
also carry a TOMM40 “risk allele” may be more dependent on
HC volume for proficient EM performance, in comparison to
“non-risk” allele carriers of these polymorphisms. Although both
TOMM40 SNPs were driving the association between HC vol-
ume and EM memory performance in APOE ε4 carriers, the two
TOMM40 SNPs are in perfect LD. However, the frequencies of
TOMM40 SNPs are not completely overlapping.
Our findings indicate that, although variation within the
TOMM40 gene does not directly influence HC volume, the poly-
morphisms seem to have an effect on HC functioning, beyond
that of APOE ε4 alone. This finding lends support to the mito-
chondrial disconnection hypothesis (Ferencz et al., 2012), sug-
gesting that there may be a mitochondrial component of HC
functioning in normal aging, with a possible TOMM40-induced
oxidative stress in HC neurons that does not influence volume per
se, but rather the function of this brain structure in old adults.
This result is in line with data demonstrating an independent
influence of TOMM40 polymorphisms on markers of neuronal
damage. Higher levels of neurofilament light proteins, a sign of
neuronal damage, have been found in the cerebrospinal fluid of
cognitively intact individuals, but only among APOE ε4 carri-
ers who do not carry the short poly-T variant of TOMM40, a
variant that is considered protective (Bruno et al., 2012). APOE
ε4 alone did not influence markers of neuronal damage suggest-
ing that it is the negative combination of the two genes that
is associated with neuronal damage. Although we did not test
markers of neuronal damage in our current sample, our find-
ings indicate that APOE ε4 may be potentially detrimental to
HC functioning only in combination with TOMM40 “risk alle-
les.” This hypothesis will have to be confirmed in future fMRI
studies.
Other studies focusing on the TOMM40 poly-T length have
shown that TOMM40 poly-T length has limited influence on
mitochondrial morphology (Hedskog et al., 2012), and levels of
amyloid and tau in cerebrospinal fluid (Pomara et al., 2011b),
suggesting that TOMM40-modulated neurotoxicity may not be
markedly present in healthy aging. Thus, in non-pathological
aging, where HC volume and EM are relatively intact (Kalpouzos
et al., 2009; Nyberg et al., 2012), mitochondrial morphology
may be well-preserved among TOMM40 “risk” allele carriers,
in line with the lack of direct influence of TOMM40 SNPs on
medial temporal lobe integrity observed in the current sam-
ple. That said, there may already be signs of TOMM40-induced
neuronal damage in old adults (Bruno et al., 2012), account-
ing for the added influence of TOMM40 (rs11556505 any T
allele, rs2075650 any G allele) on the association between HC
integrity and free recall in APOE ε4 carriers observed here. Future
studies in healthy populations taking in consideration markers
of neuronal damage and oxidative stress should confirm this
hypothesis.
One could argue that the association we observed is primar-
ily dependent on APOE ε4, as APOE and the current TOMM40
SNPs were in LD. However, the presence of an association among
APOE ε4 carriers with TOMM40 “risk alleles” speaks against this
notion. Thus, despite high LD between TOMM40 rs20756505 and
rs1155650 and APOE, there appears to be an added influence of
TOMM40 “risk alleles” on the HC volume—EM link.
LIMITATIONS
Our findings should be considered in light of some limitations.
Although we have a large sample, power concerns may still
apply with regard to the effects of the specific genes on brain
and cognition. Post-hoc power calculations were conducted uti-
lizing G∗Power3 (Faul et al., 2007). Based on the assumption
that the effect size for the genetic influence on memory perfor-
mance and HC volume is η2 = 0.1 (Rasch et al., 2010; Laukka
et al., 2013), our sample of n = 424 individuals provides suffi-
cient, albeit low, power (60%) to detect a significant difference
(α = 0.05) in memory performance between genotype groups.
In addition, our sample size was too small to examine potential
dose-response effect for the APOE ε4 allele. We did not observe
any direct influence of APOE and TOMM40 polymorphisms in
the current sample. Yet, it has been suggested that, in order to
tease out the true effects in this region that is in LD, sample sizes
of up to 20 000 would be required (Guerreiro and Hardy, 2012).
There is an inherent limitation in the cross-sectional nature
of our study and future studies should assess if TOMM40 SNPs
are associated with longitudinal changes. The current sample was
too small to assess the gene-memory link per age-cohort but
future studies with larger sample sizes should address this matter.
Thus, future longitudinal studies with larger sample sizes should
consider the independent influence of APOE and TOMM40 on
rate of brain and memory change, and how this relationship
is expressed in different age cohorts. Potential confounders that
may have influenced our findings include age, sex, and education.
However, our findings were replicated after controlling for these
confounding factors. Moreover, we limited the potential influ-
ence of incipient dementia by replicating our findings following
exclusion of preclinical dementia cases, suggesting that incipient
dementia had no influence on the current findings.
CONCLUDING REMARKS
In conclusion, we found no influence of APOE and TOMM40
polymorphisms on HC volume and EM in old adults suggesting
that variation in these genes has limited influence on brain and
cognition in non-demented adults above age 60. Our findings,
however, provide some, albeit limited, support for an added influ-
ence of TOMM40 polymorphisms (rs2075650, rs11556505) on
EM in normal aging. The aforementioned findings of the current
study suggest that individuals with the APOE ε4 allele in com-
bination with TOMM40 rs2075650 and rs11556505 “risk-alleles”
may have greater reliance on HC volume for adequate EM per-
formance. Whether the influence of the TOMM40 gene is more
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pivotal in prodromal AD remains to be seen and future follow-
up examination of the study sample should provide evidence that
speaks to this issue.
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